Intravenous Infusion Pumps Market Report Provides Insights Into Market Evolution And Growth Prospects

The intravenous infusion pumps market is set to experience remarkable expansion over the coming years, driven by technological advancements and evolving healthcare needs. As medical treatments increasingly rely on precision and patient-centered care, the demand for advanced infusion devices continues to grow. Below, we explore the market's projected growth, key players, influential trends, and detailed segment insights shaping this vital medical sector.

Projected Growth and Market Size for Intravenous Infusion Pumps
The intravenous infusion pumps market is expected to reach a substantial value of $9.98 billion by 2030, expanding at a compound annual growth rate (CAGR) of 9.4%. This surge is propelled by factors such as increasing demand for interoperable infusion devices, a stronger emphasis on patient-centric care models, and the growth of remote patient monitoring. Additionally, rising investments in smart healthcare infrastructure and the expanding adoption of home-based infusion therapies contribute significantly to this upward trend. Emerging market trends include the growing use of smart infusion pumps, dose error reduction software, integration of connected hospital systems, expanded ambulatory and home infusion therapy options, and heightened attention to medication safety.

Download a free sample of the intravenous infusion pumps market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3305&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Emerging Key Players Driving the Intravenous Infusion Pumps Market
A number of leading organizations are prominent in the intravenous infusion pumps landscape. These include B. Braun Melsungen AG, Baxter International Inc., Medtronic plc, Fresenius Kabi AG, Smiths Medical Inc., Becton dic*kinson and Company (BD), Terumo Corporation, F. Hoffmann-La Roche Ltd., ICU Medical Inc., IRadimed Corporation, Mindray Medical International Limited, Zyno Medical LLC, Tandem Diabetes Care Inc., Johnson & Johnson, Micrel Medical Devices SA, Q-Core Medical Ltd., Moog Inc., Roche Diagnostics International AG, Nipro Corporation, Animas Corporation, Ypsomed Holding AG, Valeritas Inc., ZOLL Medical Corporation, Codan Medical A/S, Halyard Health Inc., InfuSystem Holdings Inc., Hospira Infusion Systems, and CareFusion Corporation.

Strategic Acquisition Enhances Market Presence
In a significant move in May 2025, Boston Scientific, a US-based medical device company, acquired Intera Oncology, Inc. for about $172 million. This acquisition aims to bolster Boston Scientific's interventional oncology portfolio by incorporating Intera Oncology's constant-flow Intera 3000 Hepatic Artery Infusion Pump alongside the floxuridine chemotherapy drug. Together, these assets support targeted hepatic artery infusion (HAI) therapy for liver tumors. Intera Oncology is recognized for its implantable infusion pumps and drug delivery systems, particularly in hepatic artery infusion therapy.

View the full intravenous infusion pumps market report:
https://www.thebusinessresearchcompany.com/report/intravenous-infusion-pumps-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Innovations Strengthening Intravenous Infusion Pumps Market Growth
Leading companies in the intravenous infusion pumps market are heavily investing in advanced technology, such as real-time flow monitoring systems that detect and correct infusion rate deviations on the fly, improving both accuracy and patient safety. These systems continuously measure fluid flow rates during treatment to guarantee precise delivery. For example, in February 2023, Mindray, a China-based medical device manufacturer, introduced its BeneFusion I-/U Series infusion systems equipped with Smart Accurate technology. These systems monitor actual drug flow rates in real time, providing instant feedback to address any discrepancies. Additional features include user-friendly full-touch interfaces, customizable drug libraries, and a patented BolusGUARD motorized syringe loading mechanism that prevents accidental boluses during loading. Furthermore, the devices support connectivity through Mindray's M-IoT platform, enabling centralized management, maintenance analytics, and drug library updates, thus enhancing safety and operational efficiency within hospital networks.

Detailed Segmentation of the Intravenous Infusion Pumps Market
The intravenous infusion pumps market report categorizes the industry into multiple segments for a comprehensive view:
By Product: Volumetric pumps, syringe pumps, enteral pumps, ambulatory pumps, IV disposables, and other products
By Application: Chemotherapy, diabetes management, gastroenterology, analgesia/pain management, pediatrics/neonatology, hematology, and other medical uses
By End-User: Hospitals, ambulatory surgical centers, cancer treatment centers, specialty clinics, and other healthcare facilities

Further breakdowns include:
Volumetric Pumps: large-volume pumps and small-volume pumps
Syringe Pumps: micro syringe pumps and macro syringe pumps
Enteral Pumps: portable and stationary enteral pumps
Ambulatory Pumps: patient-controlled analgesia (PCA) pumps, insulin pumps, disposable pumps
IV Disposables: IV tubing sets, catheters, cannulas, and solutions
Other Products: implantable pumps, smart pumps, and elastomeric pumps

This detailed segment analysis offers a clear understanding of the market's diverse product offerings and applications, highlighting areas of growth and innovation.

What's included in our 2026 market reports:

• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.